Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4.
CD4 binds to MHC class II molecules and enhances T-cell activation. The CD4-related transmembrane protein LAG-3 (lymphocyte activation gene-3, CD223) binds to the same ligand but inhibits T-cell proliferation. We have previously shown that LAG-3 cell surface expression is tightly regulated by extracellular cleavage in order to regulate its potent inhibitory activity. Given this observation and the contrasting functions of CD4 and LAG-3, we investigated the cell distribution, location and transport of these related cell surface molecules. As expected, the vast majority of CD4 is expressed at the cell surface with minimal intracellular localization, as determined by flow cytometry, immunoblotting and confocal microscopy. In contrast, nearly half the cellular content of LAG-3 is retained in intracellular compartments. This significant intracellular storage of LAG-3 appears to facilitate its rapid translocation to the cell surface following T-cell activation, which was much faster for LAG-3 than CD4. Increased vesicular pH inhibited translocation of both CD4 and LAG-3 to the plasma membrane. While some colocalization of the microtubule organizing center, early/recycling endosomes and secretory lysosomes was observed with CD4, significantly greater colocalization was observed with LAG-3. Analysis of CD4:LAG-3 chimeras suggested that multiple domains may contribute to intracellular retention of LAG-3. Thus, in contrast with CD4, the substantial intracellular storage of LAG-3 and its close association with the microtubule organizing center and recycling endosomes may facilitate its rapid translocation to the cell surface during T-cell activation and help to mitigate T-cell activation.
Woo
Seng-Ryong
SR
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA.
Li
Nianyu
N
Bruno
Tullia C
TC
Forbes
Karen
K
Brown
Scott
S
Workman
Creg
C
Drake
Charles G
CG
Vignali
Dario A A
DA
D000818:Animals; D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism*; D015153:Blotting, Western; D015704:CD4 Antigens / Q000276:immunology / Q000378:metabolism*; D002469:Cell Separation; D005434:Flow Cytometry; D015151:Immunoblotting; D047468:Immunoprecipitation; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018613:Microscopy, Confocal; D021381:Protein Transport / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000378:metabolism*; D000093322:Lymphocyte Activation Gene 3 Protein
D015703:Antigens, CD; D015704:CD4 Antigens; D000093322:Lymphocyte Activation Gene 3 Protein; C000720327:Lag3 protein, mouse
J Exp Med. 1990 May 1;171(5):1393-405
1692078
Nat Immunol. 2009 Jan;10(1):29-37
19043418
Curr Top Microbiol Immunol. 1996;205:107-35
8575193
Immunity. 2004 Oct;21(4):503-13
15485628
J Biol Chem. 1995 Oct 20;270(42):25107-14
7559643
Immunogenetics. 1997;47(1):96-8
9382927
J Clin Invest. 2007 Nov;117(11):3383-92
17932562
J Immunol. 2000 Nov 1;165(9):5062-8
11046036
EMBO J. 2007 Jan 24;26(2):494-504
17245433
Immunogenetics. 1994;39(3):213-7
7506235
Immunity. 1996 Jun;4(6):535-43
8673700
J Exp Med. 1994 Jun 1;179(6):1945-56
7515103
Immunol Cell Biol. 1998 Feb;76(1):34-40
9553774
J Exp Med. 1992 Aug 1;176(2):327-37
1380059
Immunity. 2006 Nov;25(5):807-21
17070077
J Exp Med. 1991 Mar 1;173(3):575-87
1900077
J Cell Biol. 1992 Apr;117(2):279-90
1373141
J Immunol. 1984 Nov;133(5):2762-6
6384372
J Immunol. 2004 Dec 1;173(11):6806-12
15557174
J Immunol. 1996 Dec 1;157(11):4762-70
8943377
J Exp Med. 1993 Oct 1;178(4):1209-22
8376930
Science. 1996 Apr 19;272(5260):405-8
8602528
J Immunol. 2002 Nov 15;169(10):5392-5
12421911
J Immunol. 2005 Apr 15;174(8):4803-11
15814706
J Exp Med. 1985 Oct 1;162(4):1264-74
2413156
J Immunol. 2005 Jan 15;174(2):688-95
15634887
Eur J Immunol. 2003 Apr;33(4):970-9
12672063
Eur J Immunol. 2002 Aug;32(8):2255-63
12209638